FARMINGTON, Conn. (PRWEB) February 04, 2020
Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, has announced a new distribution partnership in Asia.
The distribution partner, Gene Company Limited, will sell Shoreline Biome’s microbiome kits and other products to companies and research organizations in China, Hong Kong, and Macau.
Gene Company Limited is a professional life science instrument and reagent supplier serving China and nearby regions. The company was established in Hong Kong in 1992.
“Distribution agreements such as these enable researchers outside the U.S. to access our transformative tools and technologies to comprehensively study all bacteria in microbiome samples,” said Bill McKenzie, Shoreline Biome's CEO. "Our all-in-one kits and software accelerate breakthroughs in microbiome research by streamlining workflows and reducing time to result.”
According to Zion Market Research, the Asia Pacific region—notably China—is expected to see the highest growth globally in human microbiome research between now and 2024.
A detailed list of Shoreline Biome’s international distributors and ordering information by country can be accessed at shorelinebiome.com/international-distributors.
For more information about Gene Company Limited, visit genecompany.com.
About Shoreline Biome:
Characterizing the human microbiome and analyzing its role in human health and disease are priority goals for researchers around the world. Shoreline Biome accelerates breakthroughs in microbiome research by developing transformative discovery tools that characterize microbiome populations down to the strain level. With Shoreline Biome products, all it takes is three easy steps: lyse, purify, and amplify. Shoreline Biome’s easy-to-use companion analysis software and comprehensive reference database enables straightforward strain-level identification and quantitation of all bacteria in the sample. To learn more, visit shorelinebiome.com.